Literature DB >> 16815254

The evaluation of light sensitivity in benign essential blepharospasm.

Wesley H Adams1, Kathleen B Digre, Bhupendra C K Patel, Richard L Anderson, Judith E A Warner, Bradley J Katz.   

Abstract

PURPOSE: To test light sensitivity thresholds rigorously in patients with benign essential blepharospasm (BEB) compared with patients who have known light sensitivity (migraineurs) and to normal control subjects.
DESIGN: Prospective, observational, case control study.
METHODS: We recruited a total of 87 subjects into each of three groups: BEB, migraine, and normal control subjects. A modified slit-lamp chin rest, heat shield, light meter, and halogen light that was modulated by a rheostat were used to measure light sensitivity thresholds. Participants were tested without spectacles, with gray-tinted spectacles, and with FL-41-tinted spectacles.
RESULTS: Light discomfort thresholds for subjects with BEB were significantly lower compared with normal control subjects (P < or = .009) and similar to the migraine group. Both gray and FL-41-tinted lenses improved light sensitivity thresholds in all groups (P < or = .0005). There was no observed difference in the improvement in light sensitivity when the gray and FL-41-tinted lenses were compared.
CONCLUSION: Patients with BEB are considerably more sensitive to light than control subjects and as sensitive to light as patients with migraine. Physicians who care for patients with BEB should consider using tinted lenses to help ameliorate symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16815254     DOI: 10.1016/j.ajo.2006.02.020

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  24 in total

Review 1.  Update on blepharospasm: report from the BEBRF International Workshop.

Authors:  Mark Hallett; Craig Evinger; Joseph Jankovic; Mark Stacy
Journal:  Neurology       Date:  2008-10-14       Impact factor: 9.910

2.  Validation of a photophobia symptom impact scale.

Authors:  Melissa M Cortez; Kathleen Digre; Durin Uddin; Man Hung; Andrea Blitzer; Jerry Bounsanga; Maren W Voss; Bradley J Katz
Journal:  Cephalalgia       Date:  2019-05-22       Impact factor: 6.292

3.  Altered pupillary light response scales with disease severity in migrainous photophobia.

Authors:  Melissa M Cortez; Natalie A Rea; Lindsay A Hunter; Kathleen B Digre; K C Brennan
Journal:  Cephalalgia       Date:  2017-04-07       Impact factor: 6.292

Review 4.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

Review 5.  Neurobiology of Photophobia.

Authors:  Rami Burstein; Rodrigo Noseda; Anne B Fulton
Journal:  J Neuroophthalmol       Date:  2019-03       Impact factor: 3.042

Review 6.  Shedding light on photophobia.

Authors:  Kathleen B Digre; K C Brennan
Journal:  J Neuroophthalmol       Date:  2012-03       Impact factor: 3.042

7.  Soft Nanomembrane Sensors and Flexible Hybrid Bioelectronics for Wireless Quantification of Blepharospasm.

Authors:  Musa Mahmood; Shinjae Kwon; Gamze Kilic Berkmen; Yun-Soung Kim; Laura Scorr; H A Jinnah; Woon-Hong Yeo
Journal:  IEEE Trans Biomed Eng       Date:  2020-02-21       Impact factor: 4.538

8.  Migraine photophobia originating in cone-driven retinal pathways.

Authors:  Rodrigo Noseda; Carolyn A Bernstein; Rony-Reuven Nir; Alice J Lee; Anne B Fulton; Suzanne M Bertisch; Alexandra Hovaguimian; Dean M Cestari; Rodrigo Saavedra-Walker; David Borsook; Bruce L Doran; Catherine Buettner; Rami Burstein
Journal:  Brain       Date:  2016-05-17       Impact factor: 13.501

9.  The effect of bangerter occlusion foils on blepharospasm and hemifacial spasm in occlusion-positive and occlusion-negative patients.

Authors:  Raman Malhotra; Siew-Yin Then; Alison Richards; Elizabeth Cheek
Journal:  Open Ophthalmol J       Date:  2010-01-15

10.  Trigeminal pathways for hypertonic saline- and light-evoked corneal reflexes.

Authors:  M Rahman; K Okamoto; R Thompson; D A Bereiter
Journal:  Neuroscience       Date:  2014-07-31       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.